Security Snapshot

Inspire Medical Systems, Inc. - Common Stock, $0.001 par value per share (INSP) Institutional Ownership

CUSIP: 457730109

13F Institutional Holders and Ownership History from Q2 2018 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

296

Shares (Excl. Options)

34,850,977

Price

$51.58

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
+1,006,897
Value change
-$107,821,202
Number of holders
296
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
28,838,196
SEC-reported price per share
$44.74
Insider filing price
$44.74
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • INSP - Inspire Medical Systems, Inc. - Common Stock, $0.001 par value per share is tracked under CUSIP 457730109.
  • 296 institutions reported positions in Q1 2026.
  • 9 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 342 to 296 between Q4 2025 and Q1 2026.
  • SEC-reported value moved from $3,125,013,462 to $1,797,502,160.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 296 institutions filings for Q1 2026.

Open SEC evidence

Security key

457730109

Latest holder period

Q1 2026

13F holders

296

13D/G owners

9

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
9
Security
INSP
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 11% -10% $248,822,799 -$29,612,330 3,353,407 -11% BlackRock, Inc. 30 Sep 2025
WELLINGTON MANAGEMENT GROUP LLP 8.8% +15% $137,296,550 +$17,588,083 2,535,954 +15% Wellington Management Group LLP 31 Mar 2026
VANGUARD PORTFOLIO MANAGEMENT LLC 5.7% $84,837,082 1,644,767 Vanguard Portfolio Management 31 Mar 2026
Soleus Capital Master Fund, L.P. 5.1% $80,994,092 1,470,748 Soleus Capital Master Fund, L.P. 26 May 2026
VANGUARD CAPITAL MANAGEMENT LLC 5.1% $75,807,281 1,469,703 Vanguard Capital Management 31 Mar 2026
Flynn James E 4.5% -12% $70,212,109 -$9,714,936 1,296,862 -12% Deerfield Mgmt, L.P. 14 May 2026
FMR LLC 2.5% -72% $55,005,358 -$130,571,372 741,312 -70% FMR LLC 30 Sep 2025
CITADEL ADVISORS LLC 1.8% -67% $50,085,615 -$112,653,375 527,217 -69% Kenneth Griffin 31 Dec 2025
WASATCH ADVISORS LP 0.5% -92% $10,084,819 -$103,003,921 135,914 -91% Wasatch Advisors LP 30 Sep 2025

As of 31 Mar 2026, 296 institutional investors reported holding 34,850,977 shares of Inspire Medical Systems, Inc. - Common Stock, $0.001 par value per share (INSP). This represents 121% of the company’s total 28,838,196 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
86%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 12% 3,549,554 -0.04% 0% $183,085,997
DEERFIELD MANAGEMENT COMPANY, L.P. 9.4% 2,703,238 +80% 1.6% $139,433,016
WELLINGTON MANAGEMENT GROUP LLP 8.8% 2,535,954 +15% 0.02% $130,804,508
VANGUARD PORTFOLIO MANAGEMENT LLC 5.7% 1,637,173 0% 0% $84,445,383
MORGAN STANLEY 5% 1,450,634 +15% 0% $74,823,729
VANGUARD CAPITAL MANAGEMENT LLC 4.4% 1,266,738 0% 0% $65,338,346
D. E. Shaw & Co., Inc. 4.1% 1,188,537 -1.9% 0.05% $61,304,738
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 3.9% 1,137,384 -2.1% 0.19% $58,666,267
STATE STREET CORP 3.3% 956,011 +4.1% 0% $49,311,047
Artisan Partners Limited Partnership 2.7% 780,575 -0.66% 0.07% $40,262,059
BRAIDWELL LP 2.3% 677,570 +25% 1.2% $34,949,061
GOLDMAN SACHS GROUP INC 2.3% 664,003 +133% 0% $34,249,275
UBS Group AG 2.2% 638,928 +55% 0.01% $32,955,906
Soleus Capital Management, L.P. 2% 576,299 +92% 1.2% $29,725,502
Vestal Point Capital, LP 1.9% 539,269 0.78% $27,815,495
Assenagon Asset Management S.A. 1.8% 520,174 +96% 0.04% $26,830,575
DEUTSCHE BANK AG\ 1.8% 513,175 -0.7% 0.01% $26,469,567
GEODE CAPITAL MANAGEMENT, LLC 1.8% 510,234 +3.8% 0% $26,324,178
Aberdeen Group plc 1.7% 477,476 +3.6% 0.04% $24,628,212
RENAISSANCE TECHNOLOGIES LLC 1.6% 469,968 +14% 0.04% $24,240,949
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 1.6% 448,787 -3.1% 0% $23,148,434
ADAR1 Capital Management, LLC 1.4% 405,197 +2601% 1.3% $20,900,061
CITADEL ADVISORS LLC 1.4% 394,076 -23% 0.01% $20,326,441
MILLENNIUM MANAGEMENT LLC 1.3% 386,146 +91% 0.01% $19,917,411
Walleye Capital LLC 1.2% 358,489 +358% 0.11% $18,490,863

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
32
Latest
Q1 2026
Rows shown
1-25 of 32
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 34,850,977 $1,797,502,160 -$107,821,202 $51.58 296
2025 Q4 33,885,583 $3,125,013,462 +$310,804,814 $92.23 342
2025 Q3 31,097,933 $2,308,932,982 -$485,546,950 $74.20 323
2025 Q2 33,831,801 $4,392,084,401 -$58,153,296 $129.77 355
2025 Q1 34,119,574 $5,429,765,770 +$100,291,872 $159.28 359
2024 Q4 33,398,911 $6,198,135,879 -$10,392,454 $185.38 352
2024 Q3 33,329,348 $7,028,206,302 -$1,705,882 $211.05 343
2024 Q2 31,606,997 $4,230,734,481 -$140,076,478 $133.83 320
2024 Q1 31,802,382 $6,833,627,583 +$185,419,402 $214.79 324
2023 Q4 31,022,012 $6,309,755,960 +$504,375,008 $203.43 344
2023 Q3 28,380,805 $5,631,853,601 -$36,280,954 $198.44 356
2023 Q2 27,993,926 $9,086,637,911 -$98,840,711 $324.64 401
2023 Q1 28,513,136 $6,673,582,259 +$65,144,358 $234.07 368
2022 Q4 28,312,278 $7,130,563,019 +$41,625,853 $251.88 333
2022 Q3 28,267,105 $5,016,328,749 +$139,991,536 $177.37 292
2022 Q2 27,431,317 $5,013,352,590 +$89,018,351 $182.67 276
2022 Q1 26,955,412 $6,916,191,060 +$287,047,237 $256.69 291
2021 Q4 25,849,229 $5,947,709,044 +$76,974,096 $230.06 283
2021 Q3 25,385,159 $5,911,432,728 +$104,134,188 $232.88 247
2021 Q2 24,992,220 $4,831,725,707 -$34,514,146 $193.26 246
2021 Q1 25,166,568 $5,209,155,369 +$94,545,681 $206.99 247
2020 Q4 25,155,650 $4,731,720,287 -$140,415,322 $188.09 237
2020 Q3 26,177,389 $3,378,475,696 -$39,929,859 $129.05 201
2020 Q2 26,892,329 $2,354,092,452 +$328,506,311 $87.02 186
2020 Q1 23,290,616 $1,403,659,501 -$140,442,230 $60.28 166
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .